Biocon Board Meeting Nov 4 to Approve Q2 FY27 Unaudited Results

Biocon Ltd has announced that its Board of Directors will convene on November 4, 2026, to approve the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Concurrently, the company will host an Earnings Conference Call for analysts and investors on the same day. The trading window for securities has been closed from October 1, 2026, to November 6, 2026, reopening on November 7, 2026, in compliance with insider trading regulations.